Publications by authors named "Regine Audran"

Claim this Profile
A
A gold nanoparticle/peptide vaccine designed to induce SARS-CoV-2-specific CD8 T cells: a double-blind, randomized, phase 1 study in Switzerland.
Juliette Besson, Régine Audran, Maxime Karlen, Alix Miauton, Hélène Maby-El Hajjami

BMC Infect Dis· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomised, double-blind, controlled phase 1 trial of the candidate tuberculosis vaccine ChAdOx1-85A delivered by aerosol versus intramuscular route.
Régine Audran, Olfa Karoui, Laura Donnet, Vassili Soumas, Fady Fares

J Infect· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a synthetic nanoparticle-based, T cell priming peptide vaccine against dengue in healthy adults in Switzerland: a double-blind, randomized, vehicle-controlled, phase 1 study.
Alix Miauton, Régine Audran, Juliette Besson, Hélène Maby-El Hajjami, Maxime Karlen

EBioMedicine· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of the phase I open label clinical trial SAKK 06/14 assessing safety of intravesical instillation of VPM1002BC, a recombinant mycobacterium Bacillus Calmette Guérin (BCG), in patients with non-muscle invasive bladder cancer and previous failure of conventional BCG therapy.
Cyrill A Rentsch, Piet Bosshard, Grégoire Mayor, Malte Rieken, Heike Püschel, Régine Audran

Oncoimmunology· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
and Orthologous Coiled-Coil Candidates for a Potential Cross-Protective Vaccine.
Imen Ayadi, Saidou Balam, Régine Audran, Jean-Pierre Bikorimana, Issa Nebie

Front Immunol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epitope Mapping and Fine Specificity of Human T and B Cell Responses for Novel Candidate Blood-Stage Malaria Vaccine P27A.
Kristina M Geiger, Daniel Guignard, Che Yang, Jean-Pierre Bikorimana, Bruno E Correia, Régine Audran

Front Immunol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Supplemental parenteral nutrition improves immunity with unchanged carbohydrate and protein metabolism in critically ill patients: The SPN2 randomized tracer study.
Mette M Berger, Olivier Pantet, Nathalie Jacquelin-Ravel, Mélanie Charrière, Sabine Schmidt, Régine Audran

Clin Nutr· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Nanofluidic IgE Assay versus a Reference Method: A Real-World Comparison.
Samuel Roethlisberger, Olfa Karoui, Daria Mapelli, Régine Audran, Vincent Aubert

Int Arch Allergy Immunol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The adjuvant GLA-SE promotes human Tfh cell expansion and emergence of public TCRβ clonotypes.
Danika L Hill, Wim Pierson, Daniel J Bolland, Catherine Mkindi, Edward J Carr, Regine Audran

J Exp Med· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Candidate Blood-stage Malaria Vaccine P27A Induces a Robust Humoral Response in a Fast Track to the Field Phase 1 Trial in Exposed and Nonexposed Volunteers.
Viviane Steiner-Monard, Kassim Kamaka, Olfa Karoui, Samuel Roethlisberger, Régine Audran

Clin Infect Dis· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reactogenicity to major tuberculosis antigens absent in BCG is linked to improved protection against Mycobacterium tuberculosis.
Nacho Aguilo, Jesus Gonzalo-Asensio, Samuel Alvarez-Arguedas, Dessislava Marinova, Ana Belen Gomez, Regine Audran

Nat Commun· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study.
Olga De Santis, Régine Audran, Emilie Pothin, Loane Warpelin-Decrausaz, Laure Vallotton

Lancet Infect Dis· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trial.
François Spertini, Régine Audran, Reza Chakour, Olfa Karoui, Viviane Steiner-Monard

Lancet Respir Med· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of immunotherapy with Bet v 1-derived contiguous overlapping peptides.
François Spertini, Yannick Perrin, Régine Audran, Céline Pellaton, Caroline Boudousquié

J Allergy Clin Immunol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of the M72/AS01 candidate tuberculosis vaccine in HIV-infected adults on combination antiretroviral therapy: a phase I/II, randomized trial.
Eleonora G Thacher, Matthias Cavassini, Régine Audran, Anne-Christine Thierry, Anne Bollaerts

AIDS· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of two oral probiotic preparations in a randomized crossover trial highlights a potentially beneficial effect of Lactobacillus paracasei NCC2461 in patients with allergic rhinitis.
Yannick Perrin, Sophie Nutten, Régine Audran, Bernard Berger, Rodrigo Bibiloni

Clin Transl Allergy· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel birch pollen specific immunotherapy formulation based on contiguous overlapping peptides.
Céline Pellaton, Yannick Perrin, Caroline Boudousquié, Nathalie Barbier, Jacqueline Wassenberg, Régine Audran

Clin Transl Allergy· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The candidate tuberculosis vaccine Mtb72F/AS02 in PPD positive adults: a randomized controlled phase I/II study.
François Spertini, Régine Audran, Floriana Lurati, Opokua Ofori-Anyinam, Frédéric Zysset

Tuberculosis (Edinb)· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toward protein biomarkers for allergy: CD4+ T cell proteomics in allergic and nonallergic subjects sampled in and out of pollen season.
Martin Blüggel, François Spertini, Petra Lutter, Jacqueline Wassenberg, Régine Audran

J Proteome Res· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized double-blind controlled Phase I/IIa trial to assess the efficacy of malaria vaccine PfCS102 to protect against challenge with P. falciparum.
Blaise Genton, Valérie D'Acremont, Floriana Lurati-Ruiz, Daniele Verhage, Régine Audran

Vaccine· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The synthetic Plasmodium falciparum circumsporozoite peptide PfCS102 as a malaria vaccine candidate: a randomized controlled phase I trial.
Régine Audran, Floriana Lurati-Ruiz, Blaise Genton, Hildur E Blythman, Opokua Ofori-Anyinam

PLoS One· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I malaria vaccine trial with a long synthetic peptide derived from the merozoite surface protein 3 antigen.
Régine Audran, Michel Cachat, Floriana Lurati, Soe Soe, Odile Leroy

Infect Immun· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A malaria vaccine that elicits in humans antibodies able to kill Plasmodium falciparum.
Pierre Druilhe, François Spertini, Daw Soesoe, Giampietro Corradin, Pedro Mejia, Regine Audran

PLoS Med· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Childhood and malaria vaccines combined in biodegradable microspheres produce immunity with synergistic interactions.
Marisa Peyre, Regine Audran, Francisco Estevez, Giampietro Corradin, Bruno Gander

J Control Release· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OM-174, a new adjuvant with a potential for human use, induces a protective response when administered with the synthetic C-terminal fragment 242-310 from the circumsporozoite protein of Plasmodium berghei.
Valentin Meraldi, Régine Audran, Jackeline F Romero, Vincent Brossard, Jacques Bauer

Vaccine· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis